Navigation Links
American Stock Exchange Accepts Encision's Plan to Regain Compliance
Date:10/4/2007

BOULDER, Colo., Oct. 4 /PRNewswire-FirstCall/ -- On October 3, 2007, Encision Inc. (Amex: ECI) ("Encision" or the "Company") received a letter from the American Stock Exchange ("AMEX") stating that AMEX has accepted the Company's plan to regain compliance with AMEX's continued listing standards, and granted the Company an extension until January 16, 2009 to regain compliance with the continued listing standards.

As previously disclosed, on July 16, 2007, the Company received a letter from AMEX stating that the Company was not in compliance with Section 1003(a)(ii) of the Amex Company Guide due to stockholders' equity of less than $4,000,000 and losses from continuing operations and/or net losses in three out of four of its most recent fiscal years. On August 15, 2007, the Company provided AMEX with information regarding its plan of compliance and financial projections. Based on a review of this information and conversations between AMEX Staff and the Company's representatives, AMEX has agreed to extend the period by which the Company must regain compliance with its listing standards until January 16, 2009.

The Company will be subject to periodic review by the AMEX Staff regarding its compliance plan during the extension period. Failure to make progress consistent with the plan could result in commencement of immediate delisting proceedings by AMEX.

Encision Inc. designs, develops, manufactures and markets innovative surgical devices that allow surgeons to optimize technique and patient safety during a broad range of surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM(R) Laparoscopic Instruments to improve electrosurgery and reduce the chance for patie
'/>"/>

SOURCE Encision Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Abstain from sex- the latest mantra of American teens
2. Clintons new problem - Is the outgoing American president suffering from skin cancer?
3. American scientists alter gene makeup of babies
4. FDA attacks American Red Cross for blood violations
5. Poll Finds Many Americans Misinformed About Cancer
6. Poll Finds Many Americans Misinformed About Cancer
7. Hypertension Drug of Choice for African Americans
8. 38 million Americans including 14 million children left to combat hunger
9. Americans Consume Far Too Much Salt and Sodium
10. Americans Growing Out Of Shape
11. Rise in Stress among Americans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... treatments targeting growth factor, researchers say , , SUNDAY, ... cancer cells from the main tumor to other parts ... known as TGFb, which may prove a promising target ... researchers say. , Previous studies have shown that TGFb ... movement. In this new study, a team from Cancer ...
(Date:12/6/2009)... Dec. 6 Blood clotting, or coagulation, ... when a blood vessel is injured. Sometimes, however, ... an obvious injury or do not dissolve naturally, ... today at the 51st Annual Meeting of the ... of using the anticoagulants aspirin and heparin with ...
(Date:12/5/2009)... a phase 1/2 clinical trial that it is ... newly diagnosed with multiple myeloma, a cancer of white ... Cancer Institute. , Partial responses or better were seen ... drug combination in the multi-center study, with 74 percent ... phase 2 population, reports Paul G. Richardson, MD, of ...
(Date:12/5/2009)... NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative ... Research presented today at the 51st Annual Meeting ... new treatment options and improved diagnostic methods for ... leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that ...
(Date:12/5/2009)... MAMA campaign is a collaborative effort by the ... Alliance of North America (MANA), Citizens for Midwifery ... American Registry of Midwives (NARM), and the Midwifery ... recent the efforts of The MAMA Campaign to ...
Breaking Medicine News(10 mins):Health News:Breast Cancer's Spread Now Better Understood 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4
... research has revealed that folic acid supplements can help ... disease //. ,Published in the July ... of the American Cancer Society, the small study found ... lesion called leucoplakia demonstrated 50 percent or greater reduction ...
... to Boston from India, on April 26, brought over for ... 18th floor of the John Hancock Tower, little did Boston ... ,On May 5 the characteristic symptoms of measles such ... struck another half-dozen workers at Investors Bank & Trust, five ...
... report looked at new prescription- only medicines that were publicly ... six years, 78 new prescription-only medicines have been listed on ... these medicines, 72 are registered in New Zealand, of which ... showed that New Zealand is slower to fund new ...
... disease the Queensland Department of Primary Industries (DPI) has ... ,Although the DPI has not yet confirmed ... effects could be serious.,The general manager of plant biosecurity, ... a trace-back and trace-forward process and would also begin ...
... The B.C government has provided $7 million towards development ... some long-awaited changes //. ,According to the ... in long-term care beds and acute care beds would ... ,However opinions differ, with Dr. Margaret MacDiarmid ...
... Medical College Hospital, Kerala they removed a five-and-a-half inch-long scissors ... Akkooppoyil Achuthan aged 65 was admitted in the hospital for ... he was discharged but frequented the hospital complaining acute pain ... scissors in the stomach. ,They team of doctors ...
Other Medicine News:Health News:Folic Acid Supplements to Prevent Cancer 2Health News:Global Threat of Measles Outbreak 2
(Date:12/4/2009)... Inc., developers of the AcceleDent System , ... announced the availability of a new Continuing Education ... leader in professional education for many industries, including ... patient views about orthodontic treatment, a summary of ...
(Date:12/4/2009)... BETHESDA, Md., Dec. 4 Northwest Biotherapeutics, Inc. ("NWBT" ... that the US Patent and Trademark Office has allowed ... the initial stages of the manufacture of the Company,s ... are key to the very high concentration of dendritic ...
(Date:12/3/2009)... Systems, a subsidiary of Hill-Rom Holdings, Inc. (NYSE: ... new Allen Amatech(TM) OEM (Original Equipment Manufacturer) business website ... reinforces the Allen Amatech(TM) brand identity and includes an ... descriptions and design specifications for the products. "We hope ...
Breaking Medicine Technology:AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Health Robotics Continues its Global Expansion With December 09 ASHPs Launch of Joint Venture in Canada 14954 1Health Robotics Continues its Global Expansion With December 09 ASHPs Launch of Joint Venture in Canada 14954 2Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 6501 1Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 6501 2Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 1Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 2Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 3
... makes proactive choice to elevate hand hygiene measures for ... ... 30 Resurgent,Health and Medical, a leader in automated handwashing ... has ordered 25 CleanTech IC handwashing systems for its locations,in ...
... 30 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced ... Annual Healthcare Focus Conference on Tuesday, October 7,2008 at ... being held at Le,Parker Meridien in New York City., ... of Anadys,will present an overview of Anadys and its ...
Other Medicine Technology:Resurgent Health and Medical Announces That Children's Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems 2Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference 2
... Nicolet VersaLab is a ... Doppler system for evaluation ... Crisp, clear Doppler sound ... a display and print-out ...
Scoliosis Devices....
... VIASYS Neurocare - continues the ... diagnosis. Exceptional convenience and speed. Superior ... ,VasoGuard delivers features you won't find ... for cuff attachment and testing. Up ...
... The Socon Spinal System is ... components with multiple mounting options. Minimal ... for spondylolisthesis. Solid clamping concept. Monosegmental ... and acceptance with over 8,000 implantations. ...
Medicine Products: